129 related articles for article (PubMed ID: 19186057)
21. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
22. Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological properties.
Ueda Y; Matiskella JD; Golik J; Connolly TP; Hudyma TW; Venkatesh S; Dali M; Kang SH; Barbour N; Tejwani R; Varia S; Knipe J; Zheng M; Mathew M; Mosure K; Clark J; Lamb L; Medin I; Gao Q; Huang S; Chen CP; Bronson JJ
Bioorg Med Chem Lett; 2003 Nov; 13(21):3669-72. PubMed ID: 14552754
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Biological Evaluation of a Novel Water-soluble Prodrug of Docetaxel with Amino Acid as a Linker.
Ma H; Chen G; Wang T; Li Q; Liu Y
Chem Biol Drug Des; 2016 Sep; 88(3):363-9. PubMed ID: 27061863
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and pharmacological evaluation of the aqueous prodrugs of desmethyl anethole trithione with hepatoprotective activity.
Chen P; Luo Y; Hai L; Qian S; Wu Y
Eur J Med Chem; 2010 Jul; 45(7):3005-10. PubMed ID: 20392547
[TBL] [Abstract][Full Text] [Related]
25. Pyrrolo[2,1-c][1,4]benzodiazepine-beta-glucuronide prodrugs with a potential for selective therapy of solid tumors by PMT and ADEPT strategies.
Kamal A; Tekumalla V; Raju P; Naidu VG; Diwan PV; Sistla R
Bioorg Med Chem Lett; 2008 Jul; 18(13):3769-73. PubMed ID: 18538566
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate (CHM-1-P-Na) as a potent antitumor agent.
Chou LC; Chen CT; Lee JC; Way TD; Huang CH; Huang SM; Teng CM; Yamori T; Wu TS; Sun CM; Chien DS; Qian K; Morris-Natschke SL; Lee KH; Huang LJ; Kuo SC
J Med Chem; 2010 Feb; 53(4):1616-26. PubMed ID: 20102207
[TBL] [Abstract][Full Text] [Related]
27. Dipeptidyl peptidase IV dependent water-soluble prodrugs of highly lipophilic bicyclic nucleoside analogues.
Diez-Torrubia A; Balzarini J; Andrei G; Snoeck R; De Meester I; Camarasa MJ; Velázquez S
J Med Chem; 2011 Mar; 54(6):1927-42. PubMed ID: 21332170
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor.
Cee VJ; Schenkel LB; Hodous BL; Deak HL; Nguyen HN; Olivieri PR; Romero K; Bak A; Be X; Bellon S; Bush TL; Cheng AC; Chung G; Coats S; Eden PM; Hanestad K; Gallant PL; Gu Y; Huang X; Kendall RL; Lin MH; Morrison MJ; Patel VF; Radinsky R; Rose PE; Ross S; Sun JR; Tang J; Zhao H; Payton M; Geuns-Meyer SD
J Med Chem; 2010 Sep; 53(17):6368-77. PubMed ID: 20684549
[TBL] [Abstract][Full Text] [Related]
29. Discovery of selective aminothiazole aurora kinase inhibitors.
Andersen CB; Wan Y; Chang JW; Riggs B; Lee C; Liu Y; Sessa F; Villa F; Kwiatkowski N; Suzuki M; Nallan L; Heald R; Musacchio A; Gray NS
ACS Chem Biol; 2008 Mar; 3(3):180-92. PubMed ID: 18307303
[TBL] [Abstract][Full Text] [Related]
30. Improvement by solid dispersion of the bioavailability of KRN633, a selective inhibitor of VEGF receptor-2 tyrosine kinase, and identification of its potential therapeutic window.
Matsunaga N; Nakamura K; Yamamoto A; Taguchi E; Tsunoda H; Takahashi K
Mol Cancer Ther; 2006 Jan; 5(1):80-8. PubMed ID: 16432165
[TBL] [Abstract][Full Text] [Related]
31. An improved design of water-soluble propofol prodrugs characterized by rapid onset of action.
Lang BC; Yang J; Wang Y; Luo Y; Kang Y; Liu J; Zhang WS
Anesth Analg; 2014 Apr; 118(4):745-54. PubMed ID: 24651228
[TBL] [Abstract][Full Text] [Related]
32. New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugs.
Almansa C; Bartrolí J; Belloc J; Cavalcanti FL; Ferrando R; Gómez LA; Ramis I; Carceller E; Merlos M; García-Rafanell J
J Med Chem; 2004 Oct; 47(22):5579-82. PubMed ID: 15481993
[TBL] [Abstract][Full Text] [Related]
33. Prodrugs of thiabendazole with increased water-solubility.
Nielsen LS; Bundgaard H; Falch E
Acta Pharm Nord; 1992; 4(1):43-9. PubMed ID: 1515051
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol.
Kumpulainen H; Järvinen T; Mannila A; Leppänen J; Nevalainen T; Mäntylä A; Vepsäläinen J; Rautio J
Eur J Pharm Sci; 2008 Jul; 34(2-3):110-7. PubMed ID: 18403185
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
Mäntylä A; Garnier T; Rautio J; Nevalainen T; Vepsälainen J; Koskinen A; Croft SL; Järvinen T
J Med Chem; 2004 Jan; 47(1):188-95. PubMed ID: 14695832
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase.
Manfredi MG; Ecsedy JA; Meetze KA; Balani SK; Burenkova O; Chen W; Galvin KM; Hoar KM; Huck JJ; LeRoy PJ; Ray ET; Sells TB; Stringer B; Stroud SG; Vos TJ; Weatherhead GS; Wysong DR; Zhang M; Bolen JB; Claiborne CF
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4106-11. PubMed ID: 17360485
[TBL] [Abstract][Full Text] [Related]
37. Design and Synthesis of Polymer Prodrugs for Improving Water-Solubility, Pharmacokinetic Behavior and Antitumor Efficacy of TXA9.
Li Y; Ye C; Cai C; Zhao M; Han N; Liu Z; Zhai J; Yin J
Pharm Res; 2020 Mar; 37(3):66. PubMed ID: 32166420
[TBL] [Abstract][Full Text] [Related]
38. Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs.
Krise JP; Zygmunt J; Georg GI; Stella VJ
J Med Chem; 1999 Aug; 42(16):3094-100. PubMed ID: 10447953
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid.
Dosa PI; Ward T; Castro RE; Rodrigues CM; Steer CJ
ChemMedChem; 2013 Jun; 8(6):1002-11. PubMed ID: 23640741
[TBL] [Abstract][Full Text] [Related]
40. Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215).
Cai ZW; Zhang Y; Borzilleri RM; Qian L; Barbosa S; Wei D; Zheng X; Wu L; Fan J; Shi Z; Wautlet BS; Mortillo S; Jeyaseelan R; Kukral DW; Kamath A; Marathe P; D'Arienzo C; Derbin G; Barrish JC; Robl JA; Hunt JT; Lombardo LJ; Fargnoli J; Bhide RS
J Med Chem; 2008 Mar; 51(6):1976-80. PubMed ID: 18288793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
